Text Size
16 studies found for:    Open Studies | "Carcinoma, Small Cell"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Study of Arsenic Trioxide in Small Cell Lung Cancer
Conditions: Lung Cancer;   Cancer of Lung;   Pulmonary Cancer;   Pulmonary Neoplasms;   Carcinoma, Small Cell
Intervention: Drug: Arsenic Trioxide
2 Recruiting Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient
Condition: Carcinoma, Small Cell
Interventions: Drug: Belotecan/Cisplatin;   Drug: Etoposide/Cisplatin
3 Recruiting N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Mesothelioma
Interventions: Drug: N-Acetylcysteine;   Drug: Placebo
4 Recruiting Metabolomic Analysis of Lung Cancer
Conditions: Carcinoma, Non-Small Cell Lung;   Carcinoma, Small Cell Lung
Intervention: Other: 13-C-glucose
5 Recruiting Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung;   Carcinoma, Small Cell Lung;   Carcinoma, Thymic
Interventions: Drug: AZD;   Drug: MK-2206;   Drug: Lapatinib;   Drug: Erlotinib;   Drug: Sunitinib;   Procedure: Molecular Profiling
6 Recruiting Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer
Condition: Small Cell Carcinoma of Lung
Intervention: Drug: Irinotecan
7 Recruiting Cabozantinib for Advanced Urothelial Cancer
Conditions: Micropapillary Cancer of the Bladder;   Squamous Cell Carcinoma of the Bladder;   Bladder Cancer With Bone Metastases;   Bladder Cancer;   Small Cell Cancer of the Bladder;   Urachal Cancer;   Sarcomatoid Bladder Cancer
Interventions: Drug: Cabozantinib;   Procedure: FDG PET CT;   Procedure: NaF PET CT
8 Recruiting Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium
Condition: Bladder Cancer
Interventions: Radiation: Prophylactic Cranial Irradiation (PCI);   Other: Brain X-ray
9 Recruiting Population-Based Stomach Cancer Registry
Conditions: Primary Stomach Carcinoma:;   Adenocarcinoma;   Papillary Adenocarcinoma;   Tubular Adenocarcinoma;   Mucinous Adenocarcinoma;   Signet-ring Cell Carcinoma;   Adenosquamous Carcinoma;   Squamous Cell Carcinoma;   Small Cell Carcinoma;   Undifferentiated Carcinoma;   Other (Specify);   Or Primary:;   Esophagogastric Junction Carcinoma;   Neuroendocrine Tumors;   GiST;   LNH
Intervention: Behavioral: Questionnaire
10 Recruiting Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Stage I Endometrial Carcinoma;   Stage IB Cervical Cancer;   Stage II Endometrial Carcinoma;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Endometrial Carcinoma;   Stage IVA Cervical Cancer
Interventions: Drug: ferumoxtran-10;   Procedure: diagnostic lymphadenectomy;   Procedure: axillary lymph node biopsy;   Procedure: 3-Tesla magnetic resonance imaging;   Procedure: positron emission tomography/computed tomography;   Radiation: fludeoxyglucose F 18
11 Unknown † Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Gemcitabine and Docetaxel
12 Recruiting Collecting Tumor Samples From Patients With Gynecological Tumors
Condition: Cancer
Intervention: Other: biologic sample preservation procedure
13 Unknown † Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer
Condition: Cervical Cancer
Interventions: Biological: panitumumab;   Drug: cisplatin;   Radiation: brachytherapy;   Radiation: external beam radiation therapy
14 Unknown † Glycoprotein and Glycan in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes
Condition: Cervical Cancer
Interventions: Genetic: microarray analysis;   Genetic: mutation analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: lymphadenectomy
15 Recruiting Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
Condition: Cervical Cancer
Interventions: Biological: live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001;   Other: laboratory biomarker analysis
16 Not yet recruiting Small Cell Cervix Survey
Condition: Cervical Cancer
Intervention: Behavioral: Questionnaires
To Top

† Indicates status has not been verified in more than two years